ArticleAlzheimer's research & therapy2019

Gantenerumab reduces amyloid-β plaques in patients with prodromal to moderate Alzheimer's disease: a PET substudy interim analysis.

Gregory Klein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.